Table 3.
Changes in routine blood parameters during the stay in May 2023.
| Parameter | Range | Baseline | End | End + 4 days | End + 14 days |
|---|---|---|---|---|---|
| Erythrocytes (million cells/µL) | 3.96-5.16 | 4.83 | 5.25 | 4.64 | 4.65 |
| Ferritin (µg/L) | 13-150 | 135 | 230 | 188 | 128 |
| Hematocrit (%) | 35-45 | 41.3 | 45.7 | 40.1 | 40.2 |
| Hemoglobin (g/dL) | 11.6-15.5 | 13.8 | 14.9 | 13.3 | 13.3 |
| Leukocytes (x103 cells/µL) | 4-10.4 | 6.6 | 5.1 | 3.9 | 4.7 |
| MCH mean corposcular hemoglobin (pg) | 26-33 | 28.6 | 28.4 | 28.7 | 28.6 |
| MCHC mean corposcular hemoglobin concentration (g/dL) | 32-36 | 33.4 | 32.6 | 33.2 | 33.1 |
| MCV mean corposcular volume (fL) | 80-96 | 85.5 | 87 | 86.4 | 86.5 |
| Platelet (x103/µL) | 176-391 | 237 | 231 | 197 | 231 |
| RDW red cell distribution width (%) | 12-15 | 13 | 13 | 13 | 14 |
| Glucose in serum (mg/dL) | 60-100 | 102 | 81 | 112 | 119 |
| HbA1c glycated hemoglobin (%) | <5.7 | 6.9 | 6.7 | 6.7 | 6.7 |
| HOMA index (ratio) | <2.5 | 3.6 | 0.9 | 2.9 | 3.3 |
| Insulin (mlU/L) | Fasting: 2-23, long-term Fasting: <6 | 14 | 4 | 11 | 11 |
| INR international normalized ratio | 0.85-1.15 | 1.13 | 1.19 | 1.16 | 1.05 |
| PTT partial thromboplastin time (sec) | 25.1-36.5 | 32 | 35 | 34 | 34 |
| Quick’s test/INR prothrombin time (%) | 70-130 | 83 | 77 | 81 | 93 |
| CRP highly sensitive c-reative protein (mg/dL) | <1 | 1 | 0.8 | 0.5 | 0.4 |
| Interleukin 6 (pg/mL) | <5.9 | 2.75 | 3.07 | 2.62 | <2.50 |
| Interleukin 8 (pg/mL) | <62 | 16 | 13 | 15 | 14 |
| Tumor necrosis factor alpha (pg/mL) | <8.1 | 7 | 6.7 | 8 | 7.6 |
| Creatinine (mg/dL) | 0.45-0.9 | 0.93 | 1.02 | 0.98 | 1.02 |
| GFR (CKD-EPI) glomerular filtration rate (mL/min) | >90 | 91 | 82 | 86 | 82 |
| Urea (mg/dL) | <50 | 21.6 | 22.5 | 17.8 | 27.5 |
| Uric Acid (mg/dL) | <6 | 7.9 | 10.2 | 8.9 | 7.5 |
| Cholesterol total (mg/dL) | <200 | 147 | 129 | 108 | 121 |
| HDL-Cholesterol (mg/dL) | >48 | 52 | 48 | 43 | 56 |
| LDL/HDL ratio | <3 | 1.6 | 1.5 | 1.2 | 1.1 |
| LDL-Cholesterol (mg/dL) | <155 | 82 | 71 | 53 | 60 |
| Non-HDL-Cholesterol (mg/dL) | <185 | 95.1 | 81.3 | 65.2 | 65.2 |
| Triglyceride (mg/dL) | <150 | 112 | 95 | 78 | 102 |
| Alkaline Phosphatase (U/L) | 35-105 | 59 | 71 | 62 | 59 |
| Gamma-GT gamma-glutamyl transferase (U/L) | <40 | 31 | 26 | 21 | 23 |
| GOT aspartate aminotransferase (U/L) | <35 | 18 | 30 | 25 | 21 |
| GPT alanine aminotransferase (U/L) | <35 | 26 | 40 | 41 | 33 |
| Calcium (mmol/L) | 2.08-2.65 | 2.38 | 2.53 | 2.38 | 2.46 |
| Magnesium (mmol/L) | 0.65-1.05 | 0.78 | 0.86 | 0.83 | 0.83 |
| Potassium (mmol/L) | 3.5-5.1 | 4.4 | 4.7 | 5.1 | 5.2 |
| Sodium (mmol/L) | 132-146 | 142 | 141 | 139 | 137 |
| TSH thyroid stimulating hormone (mE/L) | 0.3-4 | 2.5 | 1.9 | 1.8 | 1.9 |
| Homocysteine (µmol/L) | <10 | 8 | 9.5 | 6.6 | 9.4 |
| 25-hydroxy vitamin D (µg/L) | 8-56 | 18 | 25 | 26 | 28 |
Blood parameters were measured at admission (adm) and for the stay in May 2023 also at the end of the fasting period (end) and during the 4th and 14th day of food reintroduction.